These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 19138173)

  • 1. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
    Sugden MC; Priestman DA; Orfali KA; Holness MJ
    Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
    Holness MJ; Priestman DA; Sugden MC
    J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial protection from ischemic preconditioning is not blocked by sub-chronic inhibition of carnitine palmitoyltransferase I.
    Penna C; Mancardi D; Gattullo D; Pagliaro P
    Life Sci; 2005 Sep; 77(16):2004-17. PubMed ID: 15919095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm.
    Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E781-9. PubMed ID: 15166001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.
    Holloway GP; Bezaire V; Heigenhauser GJ; Tandon NN; Glatz JF; Luiken JJ; Bonen A; Spriet LL
    J Physiol; 2006 Feb; 571(Pt 1):201-10. PubMed ID: 16357012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.
    Bruce CR; Brolin C; Turner N; Cleasby ME; van der Leij FR; Cooney GJ; Kraegen EW
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1231-7. PubMed ID: 17179390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of carnitine palmitoyltransferase-1 and -2 inhibitors on rat heart hypertrophy.
    Hülsmann WC; Peschechera A; Schneijdenberg CT; Verkleij AJ
    Cardioscience; 1994 Sep; 5(3):193-7. PubMed ID: 7827256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcolemmal fatty acid uptake vs. mitochondrial beta-oxidation as target to regress cardiac insulin resistance.
    Luiken JJ
    Appl Physiol Nutr Metab; 2009 Jun; 34(3):473-80. PubMed ID: 19448717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation.
    Holloway GP; Snook LA; Harris RJ; Glatz JF; Luiken JJ; Bonen A
    J Physiol; 2011 Jan; 589(Pt 1):169-80. PubMed ID: 21041527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
    Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
    Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR.
    Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
    FEBS Lett; 2005 Apr; 579(11):2428-32. PubMed ID: 15848183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscle.
    Bezaire V; Heigenhauser GJ; Spriet LL
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E85-91. PubMed ID: 12954596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.
    Sorokina N; O'Donnell JM; McKinney RD; Pound KM; Woldegiorgis G; LaNoue KF; Ballal K; Taegtmeyer H; Buttrick PM; Lewandowski ED
    Circulation; 2007 Apr; 115(15):2033-41. PubMed ID: 17404155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
    Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes.
    Luiken JJ; Ouwens DM; Habets DD; van der Zon GC; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    J Endocrinol; 2009 May; 201(2):199-209. PubMed ID: 19273501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal control of fatty acid oxidation during the neonatal period.
    Pegorier JP; Prip-Buus C; Duee PH; Girard J
    Diabete Metab; 1992; 18(1 Pt 2):156-60. PubMed ID: 1563551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.
    Caspary F; Elliott G; Navé BT; Verzaal P; Rohrbach M; Das PK; Nagelkerken L; Nieland JD
    Br J Dermatol; 2005 Nov; 153(5):937-44. PubMed ID: 16225603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.